Anti-diarrheal
Pricing Report NDC 63868-748-12

Latest NADAC: $0.14228 per EA · Effective Aug 17, 2022
Table of Contents
  1. Current Pricing Information
  2. Pricing History

Current Package Pricing Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

The latest wholesale acquisition cost for Anti-diarrheal (NDC 63868-748-12) is $0.14228 per EA. This benchmark price is based on the National Average Drug Acquisition Cost (NADAC) and has been effective since Aug 17, 2022.

As a provided by Quality Choice (chain Drug Marketing Association), this medication is distributed in a 1 BLISTER PACK in 1 CARTON / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK configuration. The pricing data is derived from C/I - Chain or Independent Pharmacy surveys, reflecting the actual invoice prices paid by community pharmacies to drug wholesalers.

NADAC Pricing Summary

NADAC pricing snapshot for this package NDC

Acquisition Cost
$0.14228
Per EA

Pricing Unit
Per EA Pricing Unit
Indicates the billing unit (ML, GM or EA).
Effective Date
Aug 17, 2022
Data Status
As of Aug 17, 2022
Pharmacy Source Pharmacy Type Indicator
Data collected from Chain/Independent pharmacy surveys.
C/I - Chain or Independent Pharmacy
Rate Classification Classification for Rate Setting
Indicates if the NDC is Brand (B) or Generic (G).
G - Generic
Package NDC
63868-748-12
Description
1 BLISTER PACK in 1 CARTON / 12 CAPSULE, LIQUID FILLED in 1 BLISTER PACK
Pricing Methodology Explanation
The NADAC was calculated using information from the most recently completed pharmacy survey.
The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Historical Pricing Trends & Acquisition Cost Benchmarks

Since Feb 2019, the NADAC wholesale price for (NDC ) has moved within a range of $0.11842 to $0.16250 per EA. Over this 3 years and 6 months period, the pricing trend reflects the shifting acquisition costs reported by retail and chain pharmacies to the Centers for Medicare and Medicaid Services (CMS). The following interactive chart and historical table detail every recorded price adjustment based on these federal surveys.

Price Range
$0.1184 - $0.1625
Market Volatility
37.22% Variance
Latest Trend
9.59%

Recent NADAC Price History

DateUnit PriceUnitSourceMethodRate
Aug 17, 2022 $0.14228 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jul 20, 2022 $0.12983 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jun 22, 2022 $0.14171 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
May 18, 2022 $0.13594 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Apr 20, 2022 $0.14773 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Mar 23, 2022 $0.14602 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Feb 23, 2022 $0.14258 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Jan 19, 2022 $0.15202 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Dec 22, 2021 $0.13939 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Nov 17, 2021 $0.13195 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Oct 20, 2021 $0.13854 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic
Sep 22, 2021 $0.14024 EAC/I - Chain or Independent PharmacyCode 1, 6G - Generic

Earlier NADAC Price History

Pricing Methodology Legend

  • Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
  • Code 4: The NADAC was carried forward from the previous file.
  • Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.

Understanding NADAC Pricing Data

The National Average Drug Acquisition Cost (NADAC) is compiled by the Centers for Medicare and Medicaid Services (CMS). This data is derived from random monthly surveys of more than 60,000 pharmacies across all 50 states.

Important Price Distinction:

The prices listed on this page represent the wholesale invoice price paid by pharmacies to acquire the drug. This is NOT the retail price paid by consumers at the pharmacy counter. Final patient costs typically include pharmacy markups, professional dispensing fees, and insurance adjustments.

NADAC Pricing Data Last Updated on: October 07, 2026